TOP 100 WEIGHT LOSS SITES
| |||
|
| |||
| |||
|
| |||
| Empatic™ Shows Long-Term Weight Loss, Improved Quality Of Life Contrave(R) Reduces Rate Of Metabolic Syndrome By Half Orexigen Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity and other central nervous system-related disorders, today announced that the company reviewed in an oral presentation at the Obesity Society Annual Scientific Meeting that the investigational drug, Empatic™ (zonisamide SR/bupropion SR), demonstrated up to 15% reduction in body weight of healthy obese people who completed 48-weeks of treatment in the absence of diet and exercise. medicalnewstoday.com |
The Key To A Healthy Lifestyle Is In The Mind The main factors influencing the amount of physical exercise people carry out are their self-perceived ability and the extent of their desire to exercise. A study of 5167 Canadians, reported in the open access journal BMC Public Health, has shown that psychological concerns are the most important barriers to an active lifestyle. medicalnewstoday.com |
Fructose-Sweetened Beverages Linked to Heart Risks Overweight people who consumed drinks sweetened with fructose, rather than glucose, had higher blood levels of L.D.L. and triglycerides, researchers said. nytimes.com |
Women At Risk Of Gaining Excessive Weight With Injectable Birth Control Identified By UTMB Study Researchers at the University of Texas Medical Branch at Galveston have identified women who are likely to gain weight while using depot medroxyprogesterone acetate, more commonly known as Depo-Provera or the birth control shot. These findings dispel the myth that all women who use DMPA will gain weight and will help physicians to counsel patients appropriately. medicalnewstoday.com |
Links Between City Walkability And Air Pollution Exposure A new study compares neighborhoods' walkability (degree of ease for walking) with local levels of air pollution and finds that some neighborhoods might be good for walking, but have poor air quality. Researchers involved in the study include University of Minnesota faculty member Julian Marshall and University of British Columbia faculty Michael Brauer and Lawrence Frank. medicalnewstoday.com |